Scleredema diabeticorum case series: Successful treatment with UV-A1

Archives of Dermatology

Volumn 144, Issue 7, 2008, Pages 947-948

  Kroft, Elisabeth B M ^a   De Jong, Elke M G J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; HISTOPATHOLOGY; HUMAN; LETTER; PRIORITY JOURNAL; RADIATION DOSE; SCLEREDEMA; SCLEREDEMA DIABETICORUM; ULTRAVIOLET A RADIATION;

AGED; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; SCLEREDEMA ADULTORUM; ULTRAVIOLET THERAPY;

EID: 47849089241     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.7.947     Document Type: Letter

References (5)

1. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol. 1997;37(5, pt 1):793-796.
2. Mutzhas MF, Hölzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol. 1981;76(1):42-47.
3. Janiga JJ, Ward DH, Lim HW. UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed. 2004;20(4):210-211.
4. Eberlein-König B, Vogel M, Katzer K, et al. Successful UVA1 phototherapy in a patient with scleredema adultorum. J Eur Acad Dermatol Venereol. 2005;19(2):203-204.
5. Tuchinda C, Kerr HA, Taylor CR, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed. 2006;22(5):247-253.